COMBI — Combigene AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK49.50m
- -SEK34.05m
- SEK5.54m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | — | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 15.2 | 48.9 | 137 | 132 | 101 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.5 | 0.958 | 0.686 | 5.61 | 0.725 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 18.9 | 55.4 | 145 | 139 | 103 |
Net Property, Plant And Equipment | — | — | — | — | 0.851 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 43.8 | 79.4 | 166 | 158 | 121 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 23.5 | 7.98 | 7.94 | 6.1 | 4.16 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 25.4 | 7.98 | 7.94 | 6.1 | 4.16 |
Common Stock | |||||
Additional Paid In Capital | |||||
Other Equity | |||||
Total Equity | 18.5 | 71.4 | 158 | 152 | 116 |
Total Liabilities & Shareholders' Equity | 43.8 | 79.4 | 166 | 158 | 121 |
Total Common Shares Outstanding |